Peripheral Vascular Devices Market
Every Market-Reports.com study delivers in-depth market sizing, growth forecasts, competitive intelligence, segmentation analysis, and regional insights — built from company filings, government statistics and trade data, and structured for confident strategic decision-making. Request a free report preview to see its scope, chapters and methodology before you buy.
Market Snapshot
2025 Market Size
US$ 4.8 billion
Estimated Base Value
2035 Forecast
US$ 8.5 billion
Projected Market Value
CAGR 2026–2035
5.9%
Compound Annual Growth
Largest Segment
Peripheral Stents
Fastest Growing Segment
Electric Commercial Vehicles
Leading Region
North America
Fastest Growing Region
Asia Pacific
Top Country
United States
By Market Share
Largest market
Key Players
Terumo Corporation
Emerging Players
Concept Medical Inc., Reflow Medical
Peripheral Vascular Devices Market Overview
The Peripheral Vascular Devices Market encompasses medical technologies and instruments used for the diagnosis, treatment, and management of diseases affecting arteries and veins outside the heart and brain. This includes conditions such as peripheral artery disease, deep vein thrombosis, carotid artery disease, and renal artery stenosis. The market serves healthcare providers, including hospitals, ambulatory surgical centers, and specialty clinics, who utilize these devices to perform minimally invasive interventional procedures. The primary goal is to restore blood flow, prevent complications, and improve patient outcomes for those with peripheral vascular conditions.
The Peripheral Vascular Devices Market is estimated at $4.8 Bn in 2025 and is forecast to reach $8.5 Bn in 2035, growing at a CAGR of 5.9% from 2025 to 2035. Demand is driven by the rising global prevalence of peripheral artery disease, an aging population, and increased awareness leading to earlier diagnosis. However, high costs of advanced devices, stringent regulatory hurdles, and limited reimbursement policies in some regions act as restraints on market expansion.
The market is segmented by Type (Peripheral Stents, Angioplasty Balloons, Catheters, Guidewires, Vascular Closure Devices, Atherectomy Devices, Embolic Protection Devices, Inferior Vena Cava Filters), Application, End-User, Technology, Material Type, and Product Functionality. Geographically, the market is served across North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Key companies include Terumo Corporation, B. Braun Melsungen AG, Cook Medical, and Koninklijke Philips N.V. The full report provides a global market analysis, including regional breakdowns, and quantitative and qualitative analysis covering 2025-2035.
Market Definition & Overview
The Peripheral Vascular Devices Market comprises medical technologies and instruments dedicated to the diagnosis, treatment, and management of diseases affecting the arteries and veins outside of the heart and brain. This includes conditions like peripheral artery disease (PAD), deep vein thrombosis (DVT), carotid artery disease, and renal artery stenosis. The market covers a broad spectrum of devices such as angioplasty balloons, stents, atherectomy devices, thrombectomy systems, embolization coils, and IVC filters. These devices facilitate minimally invasive interventional procedures, aiming to restore blood flow, prevent complications like embolisms, and improve clinical outcomes for patients with peripheral vascular conditions.
Scope
- Global market analysis, including key regional breakdowns
- Segmentation by product type, application, and end-user
- Quantitative and qualitative analysis covering 2025-2035
- Focus on devices used in interventional peripheral vascular procedures
Inclusions
- Peripheral stents (bare-metal, drug-eluting, covered stents)
- Angioplasty balloons (plain, cutting, drug-coated balloons)
- Atherectomy devices and thrombectomy systems
- Inferior Vena Cava (IVC) filters and embolization devices
- Diagnostic catheters, guidewires, and accessories specific to peripheral vasculature
- Vascular closure devices for peripheral access sites
Exclusions
- Coronary vascular devices and cardiac rhythm management products
- Neurovascular interventional devices for cerebral conditions
- General surgical instruments not specific to peripheral vascular procedures
- Pharmaceutical drugs and biologics for peripheral vascular diseases
- Devices for open surgical repair of peripheral vessels
Market Size Forecast
Executive Summary
• The Peripheral Vascular Devices market is valued at $4.8 Bn in 2025 and is forecast to reach $8.5 Bn by 2035, reflecting a robust CAGR of 5.9% as demand accelerates across every major segment and region over the ten-year outlook.
• Peripheral Stents leads the segment breakdown by current market share, underscoring where the bulk of near-term revenue and competitive activity within this market is concentrated today.
• North America commands the largest regional share at XX.X%, while Emerging Areas is expanding the fastest at a XX.X% CAGR, signalling where future growth is shifting.
• United States remains the single largest country-level market at XX.X% of global share, anchoring overall demand within its home region throughout the forecast period.
• Intensifying M&A activity continues to reshape the competitive landscape, driving innovation focus towards integrated solutions and strengthening dominant players' market share across key therapeutic areas, particularly in emerging markets.
• Rising prevalence of peripheral artery disease, coupled with an aging global demographic and increasing awareness, critically fuels demand for advanced minimally invasive treatment options, demanding R&D investment in novel device designs.
• Technological advancements in drug-coated balloons, atherectomy devices, and bioresorbable scaffolds are significantly expanding treatment paradigms, compelling manufacturers to accelerate R&D cycles and navigate evolving regulatory pathways for market access.
• Emerging economies represent pivotal growth frontiers due to increasing healthcare infrastructure and diagnostic capabilities, requiring tailored market entry strategies and localized product portfolios to capture significant untapped patient populations.
• Pressures for value-based care and cost containment are reshaping procurement strategies and supply chain dynamics, fostering greater demand for evidence-based economic outcomes and cost-effective device innovation across health systems.
• The integration of artificial intelligence and digital health platforms into peripheral vascular devices promises enhanced diagnostic accuracy and personalized treatment, signaling a future shift towards integrated care solutions and improved long-term patient outcomes.
Key Market Takeaways
Critical findings and data points from this market research study.
Base Year Valuation
The Peripheral Vascular Devices Market was valued at $4.8 billion in the base year, reflecting its initial significant economic footprint.
Strong Growth Trajectory
The market is projected to expand at a robust Compound Annual Growth Rate (CAGR) of 5.9% through the forecast period.
Future Market Potential
By the forecast year, the market is expected to reach a substantial valuation of $8.5 billion, indicating significant future growth.
Minimally Invasive Trend
A notable trend driving market expansion is the increasing adoption of minimally invasive peripheral vascular procedures due to their patient benefits.
North America Leads
North America is anticipated to maintain a leading position in the market, primarily fueled by advanced healthcare infrastructure and high disease prevalence.
Disease Prevalence Driver
The rising global incidence of peripheral vascular diseases, often linked to an aging population and lifestyle factors, is a key market growth driver.
Market Dynamics
Market Trends
- Increasing adoption of minimally invasive peripheral vascular procedures.
- Continuous technological advancements in device materials and design.
- Growing demand for personalized and patient-specific vascular solutions.
- Wider acceptance of drug-coated balloons and innovative stent technologies.
Growth Drivers
- Rising global prevalence of peripheral artery disease (PAD).
- Aging population worldwide increasing the burden of vascular diseases.
- Enhanced awareness and early diagnosis of peripheral vascular conditions.
- Improved diagnostic imaging and interventional procedure capabilities.
Restraints
- High cost of advanced peripheral vascular devices limits adoption.
- Stringent regulatory hurdles delay new product market entry.
- Limited reimbursement policies hinder market expansion in some regions.
- Lack of skilled professionals for complex procedures is a challenge.
Opportunities
- Untapped potential in emerging economies with growing healthcare access.
- Development of novel bioresorbable scaffolds and next-gen stent technologies.
- Expansion into remote monitoring and home-based care for vascular patients.
- Integration of artificial intelligence for enhanced diagnosis and treatment planning.
Market Dynamics Framework · 2026–2035
Need Custom Data for This Market?
Get tailored segmentation, deeper competitive intelligence, or region-specific deep dives from our analyst team.
Market Segmentation
| Segment | Sub-segments |
|---|---|
| By Type | Peripheral StentsAngioplasty BalloonsCathetersGuidewiresVascular Closure DevicesAtherectomy DevicesEmbolic Protection DevicesInferior Vena Cava Filters |
| By Application | Peripheral Artery DiseaseVenous ThromboembolismCarotid Artery DiseaseAneurysm RepairCritical Limb IschemiaRenal Artery StenosisArteriovenous Fistula & Graft MaintenanceOthers |
| By End-User | HospitalsAmbulatory Surgical CentersSpecialty Clinics & Outpatient Offices |
| By Technology | Drug-Eluting TechnologyBioabsorbable TechnologyImage-Guided TechnologyAtherectomy TechnologyThrombectomy TechnologyVascular Closure TechnologyEmbolic Protection Technology |
| By Material Type | NitinolStainless SteelCobalt-Chromium AlloysPolymersBioabsorbable MaterialsDrug Coatings |
| By Product Functionality | Diagnostic DevicesTherapeutic DevicesAccess & Delivery DevicesVascular Closure DevicesEmbolic Protection Devices |
Regional Analysis
- North America leads the peripheral vascular devices market due to its high prevalence of peripheral artery disease and advanced healthcare infrastructure. Favorable reimbursement policies, significant R&D spending, and early adoption of innovative technologies also bolster its market dominance.
- Asia Pacific is emerging as the fastest-growing region for peripheral vascular devices. This surge is fueled by a rapidly aging population, increasing prevalence of diabetes and other chronic diseases, improving healthcare infrastructure, and rising disposable incomes enhancing access to advanced medical treatments.
- Europe is witnessing a notable trend towards advanced minimally invasive peripheral vascular procedures. Specifically, the increasing adoption of drug-coated balloons (DCBs) for treating peripheral artery disease is prevalent, spurred by robust clinical evidence and evolving regional treatment protocols.
| North AmericaXX.X% | EuropeXX.X% | Asia PacificXX.X% | Latin AmericaXX.X% | Middle East & AfricaXX.X% |
North America
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- A mature market with high adoption of advanced devices, driven by an aging population and high prevalence of cardiovascular diseases, though growth rates are moderate due to market saturation.
Latin America
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- Experiencing significant growth due to expanding healthcare access, increasing prevalence of diabetes and obesity, and improving economic conditions driving medical tourism and device adoption.
Europe
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- Characterized by established healthcare systems and high device penetration, with growth supported by an aging demographic and continuous innovation in device technology.
Asia Pacific
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- The fastest-growing region, fueled by rising healthcare expenditure, improving medical infrastructure, and a large patient pool with increasing awareness of peripheral vascular diseases.
Middle East & Africa
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- A rapidly developing market, supported by government investments in healthcare infrastructure and a rising burden of non-communicable diseases, especially in Gulf Cooperation Council (GCC) countries.
Country Analysis
United States and Brazil represent the largest country-level markets, with growth across the remaining countries shaped by local regulatory, infrastructure, and demand-side factors specific to each geography.
| # | Country | Market Size | CAGR | Key Driver |
|---|---|---|---|---|
| 1 | United States | US$ XX.X Mn | XX.X% | The largest market for advanced peripheral vascular devices due to high disease prevalence, robust healthcare spending, and rapid adoption of innovative treatments. |
| 2 | Brazil | US$ XX.X Mn | XX.X% | A large population coupled with an increasing prevalence of diabetes and hypertension drives the demand for peripheral vascular disease management solutions. |
| 3 | Germany | US$ XX.X Mn | XX.X% | A leading market with a strong emphasis on medical innovation, high per capita healthcare spending, and an aging demographic prone to PVD. |
| 4 | China | US$ XX.X Mn | XX.X% | Rapidly expanding healthcare infrastructure and a massive patient population with increasing PVD incidence make it a key growth engine for device adoption. |
| 5 | Saudi Arabia | US$ XX.X Mn | XX.X% | High healthcare spending, increasing prevalence of diabetes and obesity, and government investment in medical infrastructure drive market expansion. |
Countries Covered (25)
United States, Canada, Mexico, Brazil, Argentina, Rest of Latin America, Germany, United Kingdom, France, Italy, Spain, Russia, Rest of Europe, China, Japan, India, South Korea, Australia, Taiwan, Malaysia, Rest of Asia Pacific, Saudi Arabia, United Arab Emirates, South Africa, Rest of Middle East & Africa
Competitive Landscape
| # | Company | Share | Key Strategy | Key Note | Key Developments | Key Products |
|---|---|---|---|---|---|---|
| 1 | Terumo Corporation | XX.X% | Focus on global expansion and innovation, particularly in interventional cardiology and peripheral vascular therapies. | — | — | Misago Peripheral StentAtherectomy DevicesPTCA Guide Wires+1 |
| 2 | B. Braun Melsungen AG | XX.X% | Emphasize product quality and comprehensive solutions across multiple medical disciplines globally. | — | — | Vascubridge Peripheral CatheterPulsar-18 Peripheral StentSeQuent Please Peripheral DCB+1 |
| 3 | Cook Medical | XX.X% | Focus on developing minimally invasive medical devices and providing a broad portfolio of solutions for diverse clinical needs. | — | — | Zilver PTX Drug-Eluting StentEvolution Stent GraftsCXA Embolization Coils+1 |
| 4 | Koninklijke Philips N.V. | XX.X% | Integrate advanced imaging, diagnostic, and therapy solutions to improve procedural outcomes and expand precision diagnosis. | — | — | Image-Guided Therapy SystemsIntravascular UltrasoundSpectranetics Stellarex Drug-Coated Balloon+1 |
| 5 | Merit Medical Systems, Inc. | XX.X% | Expand its portfolio through strategic acquisitions and focus on interventional and diagnostic solutions for various specialties. | — | — | Embosphere MicrospheresSurefire MicrocathetersElation Pulmonary Embolism System+1 |
Market Positioning Map
Market share vs. growth outlook — bubble size is market share, bubble color is relative profitability
Companies Profiled (20)
Terumo Corporation, B. Braun Melsungen AG, Cook Medical, Koninklijke Philips N.V., Merit Medical Systems, Inc., Teleflex Inc., Penumbra, Inc., Inari Medical, Inc., AngioDynamics, Inc., BIOTRONIK SE & Co. KG, MicroPort Scientific Corporation, Lepu Medical Technology (Beijing) Co., Ltd., Endologix LLC, Surmodics, Inc., Argon Medical Devices, OrbusNeich Medical Technology Co. Ltd., Getinge AB, MedAlliance SA, Acandis GmbH, Shenzhen Relee Medical Equipment Co., Ltd. (Relisys Medical)
The global Peripheral Vascular Devices market features a competitive landscape led by Terumo Corporation, B. Braun Melsungen AG, Cook Medical, Koninklijke Philips N.V., Merit Medical Systems, Inc., and Teleflex Inc., among other established and emerging players. Market participants continue to compete on product innovation, pricing strategy, geographic expansion, and strategic partnerships to strengthen their position in this evolving market.
* Market share estimates based on company revenue disclosures and public sources; undisclosed figures are marked.
Company Profiles
Terumo Corporation
B. Braun Melsungen AG
Cook Medical
Koninklijke Philips N.V.
Merit Medical Systems, Inc.
Teleflex Inc.
Penumbra, Inc.
Inari Medical, Inc.
AngioDynamics, Inc.
BIOTRONIK SE & Co. KG
MicroPort Scientific Corporation
Lepu Medical Technology (Beijing) Co., Ltd.
Endologix LLC
Surmodics, Inc.
Argon Medical Devices
OrbusNeich Medical Technology Co. Ltd.
Getinge AB
MedAlliance SA
Acandis GmbH
Shenzhen Relee Medical Equipment Co., Ltd. (Relisys Medical)
* Classification reflects relative market share and maturity, derived from revenue analysis and public disclosures.
Ready to Make Data-Driven Decisions?
Purchase the full report or request a custom engagement. Get analyst support, scenario modelling, and real-time dashboard access.
Recent Market Developments
Medtronic Launches Next-Gen Drug-Coated Balloon for Complex PAD
Medtronic announced the global launch of its 'FlowPath DCB' system, a new drug-coated balloon designed with an enhanced drug elution profile and improved deliverability, specifically targeting challenging lesions in peripheral artery disease (PAD). Early clinical results show superior primary patency rates.
Boston Scientific Acquires Advanced Venous Stent Developer
Boston Scientific Corporation has completed its acquisition of 'VenoTech Medical', a privately held company specializing in innovative dedicated venous stent technologies for chronic venous insufficiency. This strategic move significantly strengthens Boston Scientific's peripheral interventional portfolio in the rapidly growing venous disease segment.
Philips Partners with AI Firm for Real-Time Peripheral Imaging Guidance
Royal Philips announced a new strategic partnership with 'ArteryAI Solutions', an artificial intelligence startup, to integrate AI-powered real-time imaging and procedural guidance into its peripheral vascular intervention platforms. This collaboration aims to enhance procedural precision and improve patient outcomes by optimizing catheter and device placement.
Abbott Secures FDA Approval for Novel Atherectomy System
Abbott Laboratories received U.S. FDA approval for its 'VesselClean Atherectomy System', a new device designed for the effective removal of plaque from peripheral arteries in patients with peripheral artery disease (PAD). This approval expands Abbott's atherectomy offerings, providing clinicians with another tool for complex lesion treatment.
Report Data Parameters
| Parameter | Value |
|---|---|
| Base Year | 2025 |
| Forecast Year | 2035 |
| Historical Period | 2019–2025 |
| Market Size (Base Year) | $4.8 Bn |
| Market Size (Forecast) | $8.5 Bn |
| CAGR | 5.9% |
| Forecast Period | 2026–2035 |
| Geography | Global |
| Countries Covered | 25 Countries |
| Segments Covered | 6 Segments, 37 Sub-segments |
| Companies Profiled | 32 Companies |
Report Value
Why Choose This Report
Complete Market Size
Market sizing for the base year and a 10-year forecast across three scenarios.
Segment Analysis
Deep-dive segmentation by product, application, end-user, and technology verticals.
Country Analysis
Country-level market data for every country in the report scope, across all major regions.
Company Profiles
Profiles of the leading companies, with disclosed financials, strategy and market share.
Market Share
Detailed competitive market share analysis with trend mapping and benchmarking.
Competitive Intelligence
SWOT, Porter's Five Forces, and competitive positioning across market leaders.
Scenario Analysis
Three-scenario modelling (Base / Optimistic / Conservative) with CAGR decomposition.
Regulatory Review
Regulatory landscape, compliance requirements, and policy impact analysis by region.
Strategic Analysis · Management Insights · CXO Insights
Executive Strategic & Intelligence Report
A board-ready strategic deck built on the Peripheral Vascular Devices Market report: eleven chapters and an appendix, from market sizing to the board decisions, delivered as a PDF with an Excel datapack. US$3,000 per market, prepared after your order.
What to expect in the Executive Report for this market
- About 400 slides, 11 chapters and an appendix. Built on this report's own numbers, so every figure matches the report and the Excel.
- Market size and forecast to 2035. By segment, sub-segment, region and country, with conservative, base and optimistic cases.
- An analysis page after every exhibit. The key insight, ten specific points and the decision it implies for leaders, challengers, entrants and investors.
- Competitive intelligence. Shares and positioning, capability benchmark, strategies, recent moves and acquisition screening.
- Customers, technology and business models. Who buys and why, AI and technology impact, pricing, channels and go-to-market by segment.
- Risks and scenarios. Risk register, four future scenarios with signposts, and early-warning indicators with thresholds.
- Opportunities and the board decisions. Opportunity scoring, strategic options, roadmap, capability gaps, decision matrix and a 90-day plan.
- PDF, Excel datapack and PowerPoint. A bookmarked PDF, the full Excel datapack and editable infographic slides for your own decks.
US$3,000 per market · bought online, prepared after your order and emailed to you
See a full example report →Only need the headline view? Market Snapshot (PDF) + Excel Datasheet · 10–20 slide PDF + Excel
A CEO-level executive summary of the market in 10–20 slides - size and forecast, growth by segment and region, the leading countries and companies, key trends and the outlook - plus the Excel datasheet. A short executive view of this market, not the full analysis - PDF and Excel, prepared and emailed to you after your order.
Trusted by strategy teams, investors & global enterprises
What Our Clients Say
Verified reviews from enterprise clients
“The depth of analysis and quality of data is unparalleled. This report directly informed our $50M market expansion strategy and helped us prioritise the right geographies.”
VP, Corporate Strategy
Industrial manufacturing company
“Exceptional research quality. The competitive landscape section alone saved our team months of primary research effort and gave us a clear view of the opportunity.”
Director, Investment Research
Private equity firm
“We now use these reports in every planning cycle. The regional granularity, and the same numbers across the report, the dashboard and the Excel, save our team real time.”
Head of Market Intelligence
Specialty chemicals company
Frequently Asked Questions
Common questions about this report and our research
The Peripheral Vascular Devices Market is estimated at $4.8 Bn in 2025. It is forecast to reach $8.5 Bn in 2035, indicating substantial growth over the decade.
The Peripheral Vascular Devices Market is forecast to grow at a Compound Annual Growth Rate (CAGR) of 5.9% from 2025 to 2035. This growth reflects increasing demand for these medical technologies.
The main segments include Peripheral Stents, Angioplasty Balloons, Catheters, Guidewires, and Vascular Closure Devices by type. Applications cover Peripheral Artery Disease and Venous Thromboembolism, while end-users include Hospitals and Ambulatory Surgical Centers.
Leading companies in this market include Terumo Corporation, B. Braun Melsungen AG, Cook Medical, Koninklijke Philips N.V., Merit Medical Systems, Inc., Teleflex Inc., and Penumbra, Inc.
The report provides a global market analysis, including key regional breakdowns, and segmentation by product type, application, and end-user. It offers quantitative and qualitative analysis covering the period from 2025 to 2035.
The Single User and Enterprise licences include the full PDF report, the PowerPoint (PPT), the Excel data workbook and the interactive Online Dashboard. The Online Dashboard gives online access to the snapshot and datasheet with export features, and the Market Snapshot is an executive summary in PDF with the Excel data sheet.
Yes. Request a free report preview: its scope, every chapter and what it contains, the methodology and the headline figures. The full report is a paid product.
We accept credit/debit cards (Visa, Mastercard, Amex), bank wire transfer, and purchase orders for enterprise clients. All transactions are secured with 256-bit SSL encryption.
Buy This Report
Choose the format that fits your budget
Digital delivery — all sales are final. See our Refund Policy and Terms & Conditions.
Strategic deck for this market
Executive Strategic & Intelligence Report
About 400 board-ready slides: every exhibit with its analysis and the decision it implies. Prepared for this market after your order and emailed to you.
Need to go deeper?
Intelligence services for this market
- Competitor benchmarking →
- Market entry & expansion →
- Product & growth opportunities →
- Investment & acquisition due diligence →
What's Included
Similar Reports
Vascular Closure Devices Market
$1.9 Bn in 2025 · 6.3% CAGR
Audiology Devices Market
$12.9 Bn in 2025 · 5.7% CAGR
Autotransfusion Devices Market
$310.0 Mn in 2025 · 5.1% CAGR
Cardiac Monitoring Devices Market
$6.4 Bn in 2025 · 6.0% CAGR
Connected Medical Devices Market
$28.0 Bn in 2025 · 12.5% CAGR
Endoluminal Suturing Devices Market
$500.0 Mn in 2025 · 12.3% CAGR
Pregnancy Monitoring Devices Market
$1.7 Bn in 2025 · 8.4% CAGR
Sleep Apnea Devices Market
$10.8 Bn in 2025 · 12.3% CAGR